Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression in activated WT or PDK4 -/- CD4+ T cells

ABSTRACT: Activation of CD4+ T cells requires metabolic reprograming to sustain demands of cellular building blocks and ATP. Pyruvate dehydrogenase kinase (PDK) is an enzyme regulating pyruvate dehydrogenase complex subunit alpha 1 (PDHE1-alpha), which converts pyruvate to acetyl-CoA. Gene expression analysis of TCR-stimulated CD4+ T cells with PDK4 deletion exhibited the reduced calcium signaling and aerobic glycolysis pathway.

ORGANISM(S): Mus musculus

PROVIDER: GSE161653 | GEO | 2022/11/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging

Project description:Pyruvate Dehydrogenase Kinase 4 (Pdk4) is a pyruvate dehydrogenase inhibiton gene that strongly regulates metabolism. We studied the expression of Pdk4 in the young and aged mouse heart in both healthy conditions and after ischemic insult.

2023-01-31 | GSE213080 | GEO

Transcriptomic landscape of human primary stromal cells upon chemotherapeutic and/or PDK4-specific intervention

Project description:Cellular senescence is a response elicited by acute or chronic damage signals. In humans, senescent cells accumulate in multiple tissues at different rates, from 2- to 20-fold when comparing young (<35 years) to old (>65 years) healthy donors. The pathogenic role of cellular senescence in diverse age-related diseases can be largely explained by the senescence-associated secretory phenotype (SASP). Senescent cells display changes in mitochondrial activity with increased ATP production and high lactate production, which are partially correlated with upregulation of pyruvate dehydrogenase kinase 4 (PDK4), an inhibitor of mitochondrial pyruvate dehydrogenase. We used a genotoxic agent, bleomycin, and/or a PDK4-targeting chemical, PDK4-IN, to treat human primary stromal cells and determined the influence of PDK4 inhibition on the transcriptomic expression profile of senescent cells. The data allow to disclose the importance of PDK4 activity in development of senescence-associated phenotypes, particularly the SASP.

2023-09-05 | GSE222279 | GEO

Global profiling of prostate cancer cell expression upon treatment with media conditioned from human stromal cells ectopically expressing PDK4

Project description:Technical advances in next generation sequencing (NGS) has revolutionized system-based analysis of genome-wide expression, cellular pathways and responses. We performed this study to establish the transcriptomic profiles of human prostate cancer cell lines exposed to conditioned media from human primary stromal cells engineered to express pyruvate dehydrogenase kinase 4 (PDK4), a key enzyme that is correlated with glucose metabolism, negatively regulates the conversion of pyruvate to acetyl-CoA and plays important roles in cancer progression and multiple other pathological events.

2023-09-05 | GSE198110 | GEO

STAT3-dependent systems-level analysis reveals PDK4 to be associated with favorable outcome in primary prostate cancer.

Project description:Prostate cancer has a broad spectrum of clinical behavior, hence biomarkers are urgently needed for risk stratification. We previously described the protective effect of signal transducer and activator of transcription 3 (STAT3) in a prostate cancer mouse model. We now show the importance of STAT3-regulated metabolic functions and explain their influence on aggressive prostate cancer. By utilizing a gene co-expression network in addition to laser microdissected proteomics from human and murine FFPE samples, we established a workflow that facilitates the discovery of new biomarkers. We thereby identified the protective effect of pyruvate dehydrogenase kinase 4 (PDK4) in prostate cancer. PDK4 is a key regulator of the citrate cycle and low PDK4 is significantly associated with disease recurrence.

2020-04-22 | PXD014251 | Pride

Pdk4

Project description:Rattus norvegicus Pdk4, pyruvate dehydrogenase kinase 4 [Source:RGD Symbol;Acc:69061], is differentially expressed in 41 experiment(s);

| ENSRNOG00000009565 | ExpressionAtlas

Pdk4

Project description:Rattus norvegicus Pdk4, pyruvate dehydrogenase kinase 4 [Source:RGD Symbol;Acc:69061], is expressed in 6 baseline experiment(s);

| ENSRNOG00000009565 | ExpressionAtlas

PDK4

Project description:Sus scrofa PDK4, pyruvate dehydrogenase kinase 4 [Source:VGNC Symbol;Acc:VGNC:91280], is differentially expressed in 7 experiment(s);

| ENSSSCG00000015334 | ExpressionAtlas

PDK4

Project description:Oryctolagus cuniculus PDK4, pyruvate dehydrogenase kinase 4 [Source:HGNC Symbol;Acc:HGNC:8812], is expressed in 1 baseline experiment(s);

| ENSOCUG00000017120 | ExpressionAtlas

PDK4

Project description:Equus caballus PDK4, pyruvate dehydrogenase kinase 4 [Source:VGNC Symbol;Acc:VGNC:21271], is expressed in 1 baseline experiment(s);

| ENSECAG00000008335 | ExpressionAtlas

PDK4

Project description:Homo sapiens PDK4, pyruvate dehydrogenase kinase 4 [Source:HGNC Symbol;Acc:HGNC:8812], is expressed in 44 baseline experiment(s);

| ENSG00000004799 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data